The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> BIOLOGY >> NEWS
Discovery Of Mechanism Causing Colon Cancer

REHOVOT, Israel - May 11, 1999 -WeizmannInstitute researchers have discovered a molecular mechanism that may be involved in causing colon cancer,according to a study reported in the May 11 issue of the Proceedings of the National Academy of Sciences.

This research may one day contribute to the development of potential therapies for this type of malignancy and possibly for other types of cancer as well.

The discovery of the new mechanism has solved two seemingly unrelated molecular mysteries.

One concerned an important finding made some two years ago: the fact that colon cancer cells often have abnormally large quantities of a protein called beta- catenin, one of today's "hottest" research molecules. Beta-catenin has been dubbed a"moonlighter" because it holds down two distinct cellular jobs. In its better-known task, beta-catenin binds to adhesion molecules - those molecules that sit in the cellular membrane and allow cells to stick together. In its other role, beta-catenin is known to regulate the performance of genes in the nucleus. However, how exactly beta-catenin does this - and which genes it controls - remained unclear.

The second molecular mystery centered around the gene cyclin D1 - a major regulator of cell growth which, when mutated, can act as an oncogene, or gene that causes cancer. The levels of the protein produced by this gene are abnormally high in about 30 percent of colon cancers, indicating that cyclin D1 may be involved in malignant transformation. However, the cyclin D1 gene found in colon cancer cells is perfectly normal. This baffled researchers because usually oncogenes cause cancer only when they appear in mutated form.

A team of researchers led by Prof. Avri Ben-Ze'ev of the Weizmann Institute's Molecular Cell Biology Department, in collaboration with the group of Dr. Richard Pestell from the Albert Einstein College of Medicine in New York, has now put these two mysterious puzzle pieces together
'"/>

Contact: Arthur Berger, VP Public Policy & Marketing
arthur@acwis.org
212-779-2500, Ext. 1
American Committee for the Weizmann Institute of Science
11-May-1999


Page: 1 2 3

Related biology news :

1. Discovery of new shrimp species adds to unique family
2. Discovery of tiny microbes in ancient Greenland glacier may define limits for life on Earth
3. Discovery in parasite movement may offer insights into malaria
4. Scientists find second way to kill cancer cells: Discovery opens possibilities for new therapies
5. GlaxoSmithKline Drug Discovery and Development Research Grant Program 2004
6. Discovery helps explain how cells package DNA
7. Discovery offers clues to origin of life
8. Discovery could improve anemia treatment in patients
9. Discovery could lead to better treatment for cryptosporidum infections
10. Discovery of brain disorder gene paves way for genetic test
11. Discovery may be first plant cell surface molecule that halts cell proliferation

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Discovery Mechanism Causing Colon Cancer

(Date:11/23/2009)...e highest resolution images of peptides attaching ...rstanding how biomolecules manipulate the growth c... for kidney stones using biomolecules. , The res... of the journal Proceedings of the National Acade...th mineral surfaces by accelerating, switching and...
(Date:11/23/2009)...sity of Alabama at Birmingham (UAB) researchers sh...ical conditions (co-morbidity) do not explain the ...s compared to Caucasians who also have colon cance...r , a journal of the American Cancer Society. , ...bidity are independent predictors of poor survival...
(Date:11/23/2009)...unprecedented detail how the ribosome interacts wi...ide them toward their destination in biological ce...fitting (MDFF) to examine the interaction of the r... The first study, in Proceedings of the National...ling between the ribosome and an elongation factor...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3China Biologic Products to Attend at Susquehannas Third Annual Beijing Management Summit 13968 1China Biologic Products to Attend at Susquehannas Third Annual Beijing Management Summit 13968 2China Biologic Products to Attend at Susquehannas Third Annual Beijing Management Summit 13968 3Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single Stranded RNAi Technology 56731 1Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single Stranded RNAi Technology 56731 2Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single Stranded RNAi Technology 56731 3Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single Stranded RNAi Technology 56731 4Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single Stranded RNAi Technology 56731 5Isis Receives Notice of Allowance That Expands the Scope of Key RNA Therapeutic Patents for Single Stranded RNAi Technology 56731 6NovaBay Launches Clinical Study for Non Antibiotic Treatment of Impetigo One of the Most Common Skin Infections 4960 1NovaBay Launches Clinical Study for Non Antibiotic Treatment of Impetigo One of the Most Common Skin Infections 4960 2NovaBay Launches Clinical Study for Non Antibiotic Treatment of Impetigo One of the Most Common Skin Infections 4960 3NovaBay Launches Clinical Study for Non Antibiotic Treatment of Impetigo One of the Most Common Skin Infections 4960 4
(Date:11/19/2009)...wswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NB...g letter to its shareholders, discussing the Compa...opharmaceuticals Holdings, Inc. (CHBP), an integra...,s Republic of China. The merger gives NeoStem a c...cal Co. Ltd., CHBP,s primary operating subsidiary ...
(Date:11/19/2009)..., November 19 MONITORING FORCE Gmb... 2009 Flibanserin in the,indication treatment-rele...sease for orphan drug status designation with the ... dyskinesia is a complication of the mainstay,trea... to some of those,affected, since it may be disabl...
(Date:11/19/2009)...Top Gene Synthesis Companies Form International Ge...Practices in Risk Reduction ,Five Member Compani...s Capacity , (PRWEB) Nove... gene synthesis companies today announced agreemen... to promote biosecurity in the gene synthesis indu...
(Date:11/18/2009)...PRNewswire/ -- Marrone Bio Innovations (MBI), a le...zation of effective and environmentally responsibl...been named an IC20 company by the Investors, Circl...angel investing group. ,, Companies named to th...esults for all stakeholders, including investors, ...
Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4Marrone Bio Innovations Named an IC20 Company 2
Other News:
...ovative medical discovery that has the potential t...m coronary artery disease was implanted today in t... developed by Dr. Michael Kutryk, a cardiologist a... and assistant professor, University of Toronto, w...
CHAPEL HILL -- Adults with attention-deficit-hyperactivity disorder treated long term with an extended-release mixed-salts amphetamine medication maintained significant symptom improvement with good t
...environmental policy makers are increasingly losin...elopment, as the government has shifted its focus ... new research funded by the Economic & Social Rese...ulation in local environmental policy making was c...
...es of cultured organisms threaten native biodivers...pecies such as farm Atlantic salmon (Salmo salar L...e spread of domesticated traits in the wild was re...of males escaping from marine netpens. Recent evid...
Antibody coated stent a breakthrough in cardiovascular treatment 2Study: Adults maintain significant improvement in ADHD with long-term use of amphetamine 2Study: Adults maintain significant improvement in ADHD with long-term use of amphetamine 3Study: Adults maintain significant improvement in ADHD with long-term use of amphetamine 4Environment loses to economic development in local policy-making 2
...a new molecule that may help regulate the delivery...blished in the April issue of the journal Cell Met...tanding of how we utilize fats from the foods we e...e body digests and uses fats, but we have identifi...
...caused by hypoglycemic coma actually occurs when g...g to a study in rodents led by researchers at the ...re surprising, say the authors, and may be of clin...n hypoglycemic coma, though they caution that the ...
...ime, scientists from the University of Washington ... and the University of Cambridge have determined h...hormone receptor, called TIR1. Their report, on th...ave important implications for the treatment of hu...
...pies often work only partially or not at all, and ...t-Ingram Cancer Center scientists have now linked ...uture spread. ... The team led by Carlos Arteaga, ...linical Investigation that radiation and chemother...
UCLA identifies new molecule involved in the body's processing of dietary fat 2Glucose triggers brain cell death in rats after hypoglycemic coma 2Glucose triggers brain cell death in rats after hypoglycemic coma 3Discovery in plants suggests entirely new approach to treating human cancers 2Treatment-induced growth factor causes cancer progression 2